Search Results

PX-478 25 mg  | Purity Not Available

TargetMol

PX-478 2HCl is an orally active, and selective inhibitor of hypoxia-inducible factor-1α (HIF-1α).

More Information Supplier Page

PX-478 2 mg  | Purity Not Available

TargetMol

PX-478 2HCl is an orally active, and selective inhibitor of hypoxia-inducible factor-1α (HIF-1α).

More Information Supplier Page

P005091 100 mg  | Purity Not Available

TargetMol

P005091 is a selective and potent inhibitor of ubiquitin-specific protease 7 (USP7) with EC50 of 4.2 μM.

More Information Supplier Page

P005091 5 mg  | Purity Not Available

TargetMol

P005091 is a selective and potent inhibitor of ubiquitin-specific protease 7 (USP7) with EC50 of 4.2 μM.

More Information Supplier Page

Leucomethylene blue mesylate 5 mg  | Purity Not Available

TargetMol

Leucomethylene blue mesylate (TRx0237 mesylate) is a second-generation tau protein aggregation inhibitor for the treatment of Alzheimer’s disease (AD) and frontotemporal dementia.

More Information Supplier Page

Leucomethylene blue mesylate 25 mg  | Purity Not Available

TargetMol

Leucomethylene blue mesylate (TRx0237 mesylate) is a second-generation tau protein aggregation inhibitor for the treatment of Alzheimer’s disease (AD) and frontotemporal dementia.

More Information Supplier Page

Upadacitinib 25 mg  | 99.93%

TargetMol

Upadacitinib (ABT-494) is a selective Janus kinase (JAK) 1 inhibitor, which is being studied for the treatment of several autoimmune disorders in the IC50 of 43 nM.

More Information Supplier Page